Výsledky vyhledávání

Akademický článek

Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma.

Autor: Sobol NT; Center of Molecular and Translational Oncology, National University of Quilmes, Bernal B1876BXD, Buenos Aires, Argentina., Solernó LM; Center of Molecular and Translational Oncology, National University of Quilmes, Bernal B1876BXD, Buenos Aires, Argentina., Beltrán B; Precision Medicine Research Center, School of Medicine, University of San Martín de Porres, Lima 15024, Perú., Vásquez L; Precision Medicine Research Center, School of Medicine, University of San Martín de Porres, Lima 15024, Perú., Ripoll GV; Center of Molecular and Translational Oncology, National University of Quilmes, Bernal B1876BXD, Buenos Aires, Argentina.; National Council of Scientific and Technical Research (CONICET), Buenos Aires C1425FQB, Argentina., Garona J; Center of Molecular and Translational Oncology, National University of Quilmes, Bernal B1876BXD, Buenos Aires, Argentina.; National Council of Scientific and Technical Research (CONICET), Buenos Aires C1425FQB, Argentina., Alonso DF; Center of Molecular and Translational Oncology, National University of Quilmes, Bernal B1876BXD, Buenos Aires, Argentina.; National Council of Scientific and Technical Research (CONICET), Buenos Aires C1425FQB, Argentina.

Publikováno v: Experimental and therapeutic medicine [Exp Ther Med] 2021 Jun; Vol. 21 (6), pp. 566. Date of Electronic Publication: 2021 Mar 26.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial.

Autor: Iseas S; Oncology Unit, Gastroenterology Hospital Bonorino Udaondo, Buenos Aires, Argentina., Roca EL; Oncology Unit, Gastroenterology Hospital Bonorino Udaondo, Buenos Aires, Argentina., O'Connor JM; Department of Clinical Oncology, Alexander Fleming Institute, Buenos Aires, Argentina., Eleta M; Onco-imaging Area, Imaxe Center for Diagnostic, Buenos Aires, Argentina., Sanchez-Luceros A; Thrombosis and Hemostasis Department, IMEX and IIHEMA, National Academy of Medicine, Buenos Aires, Argentina., Di Leo D; Elea-Phoenix Laboratories, Los Polvorines, Argentina., Tinelli M; Elea-Phoenix Laboratories, Los Polvorines, Argentina., Fara ML; Elea-Phoenix Laboratories, Los Polvorines, Argentina., Spitzer E; Elea-Phoenix Laboratories, Los Polvorines, Argentina., Demarco IA; Chemo-Romikin, Buenos Aires, Argentina., Ripoll GV; Laboratory of Molecular Oncology, National University of Quilmes, Bernal, Argentina., Pifano M; Laboratory of Molecular Oncology, National University of Quilmes, Bernal, Argentina., Garona J; Laboratory of Molecular Oncology, National University of Quilmes, Bernal, Argentina., Alonso DF; Laboratory of Molecular Oncology, National University of Quilmes, Bernal, Argentina. dfalonso@unq.edu.ar.

Publikováno v: Investigational new drugs [Invest New Drugs] 2020 Oct; Vol. 38 (5), pp. 1580-1587. Date of Electronic Publication: 2020 Mar 12.

Zobrazit plný text záznamu

Akademický článek

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer.

Autor: Ripoll GV; Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina.; Scientific Investigator Career of National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina., Pifano M; Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina., Garona J; Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina.; Scientific Investigator Career of National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina., Alonso DF; Laboratory of Molecular Oncology, Department of Science and Technology, National University of Quilmes, Bernal, Argentina.; Scientific Investigator Career of National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina.

Publikováno v: Frontiers in oncology [Front Oncol] 2020 Jan 10; Vol. 9, pp. 1490. Date of Electronic Publication: 2020 Jan 10 (Print Publication: 2019).

Zobrazit plný text záznamu

Akademický článek

Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.

Autor: Garona J; Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina., Sobol NT; Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina., Pifano M; Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina., Segatori VI; Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina., Gomez DE; Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina., Ripoll GV; Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina., Alonso DF; Laboratory of Molecular Oncology, Science and Technology Department, National University of Quilmes, Buenos Aires, Argentina.

Publikováno v: Cancer research and treatment [Cancer Res Treat] 2019 Apr; Vol. 51 (2), pp. 438-450. Date of Electronic Publication: 2018 Jun 01.

Zobrazit plný text záznamu

Akademický článek

Search of vasopressin analogs with antiproliferative activity on small-cell lung cancer: drug design based on two different approaches.

Autor: Pifano M; Laboratory of Molecular Oncology, Quilmes National University, Buenos Aires, 1876, Argentina., Garona J; Laboratory of Molecular Oncology, Quilmes National University, Buenos Aires, 1876, Argentina., Sobol NT; Laboratory of Molecular Oncology, Quilmes National University, Buenos Aires, 1876, Argentina., Albertó M; Laboratory of Molecular Oncology, Quilmes National University, Buenos Aires, 1876, Argentina., Alonso DF; Laboratory of Molecular Oncology, Quilmes National University, Buenos Aires, 1876, Argentina., Ripoll GV; Laboratory of Molecular Oncology, Quilmes National University, Buenos Aires, 1876, Argentina.

Publikováno v: Future medicinal chemistry [Future Med Chem] 2018 Apr 01; Vol. 10 (8), pp. 879-894. Date of Electronic Publication: 2018 Mar 28.

Zobrazit plný text záznamu

Akademický článek

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells.

Autor: Pifano M; Laboratory of Molecular Oncology, Quilmes National University , Bernal, Buenos Aires , Argentina., Garona J; Laboratory of Molecular Oncology, Quilmes National University , Bernal, Buenos Aires , Argentina., Capobianco CS; Laboratory of Molecular Oncology, Quilmes National University , Bernal, Buenos Aires , Argentina., Gonzalez N; Laboratory of Molecular Oncology, Quilmes National University , Bernal, Buenos Aires , Argentina., Alonso DF; Laboratory of Molecular Oncology, Quilmes National University , Bernal, Buenos Aires , Argentina., Ripoll GV; Laboratory of Molecular Oncology, Quilmes National University , Bernal, Buenos Aires , Argentina.

Publikováno v: Frontiers in oncology [Front Oncol] 2017 Jan 30; Vol. 7, pp. 11. Date of Electronic Publication: 2017 Jan 30 (Print Publication: 2017).

Zobrazit plný text záznamu

Akademický článek

Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.

Autor: Garona J; Laboratory of Molecular Oncology, National University of Quilmes, Roque Saenz Peña 352, B1876BXD, Bernal, Buenos Aires, Argentina. juan.garona@unq.edu.ar., Pifano M; Laboratory of Molecular Oncology, National University of Quilmes, Roque Saenz Peña 352, B1876BXD, Bernal, Buenos Aires, Argentina., Pastrian MB; Laboratory of Molecular Oncology, National University of Quilmes, Roque Saenz Peña 352, B1876BXD, Bernal, Buenos Aires, Argentina., Gomez DE; Laboratory of Molecular Oncology, National University of Quilmes, Roque Saenz Peña 352, B1876BXD, Bernal, Buenos Aires, Argentina., Ripoll GV; Laboratory of Molecular Oncology, National University of Quilmes, Roque Saenz Peña 352, B1876BXD, Bernal, Buenos Aires, Argentina., Alonso DF; Laboratory of Molecular Oncology, National University of Quilmes, Roque Saenz Peña 352, B1876BXD, Bernal, Buenos Aires, Argentina.

Publikováno v: Clinical & experimental metastasis [Clin Exp Metastasis] 2016 Aug; Vol. 33 (6), pp. 589-600. Date of Electronic Publication: 2016 May 05.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání